Compare CTW & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTW | LNSR |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.9M | 136.8M |
| IPO Year | 2025 | N/A |
| Metric | CTW | LNSR |
|---|---|---|
| Price | $1.91 | $11.81 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 58.4K | 42.5K |
| Earning Date | 11-17-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $90,370,793.00 | $59,141,000.00 |
| Revenue This Year | N/A | $19.55 |
| Revenue Next Year | N/A | $35.89 |
| P/E Ratio | $30.87 | ★ N/A |
| Revenue Growth | ★ 32.07 | 21.02 |
| 52 Week Low | $1.71 | $7.25 |
| 52 Week High | $4.88 | $17.31 |
| Indicator | CTW | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 56.61 |
| Support Level | N/A | $11.19 |
| Resistance Level | N/A | $11.81 |
| Average True Range (ATR) | 0.00 | 0.32 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 0.00 | 60.59 |
CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.